{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:50:44Z","timestamp":1786503044861,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-1-0693"],"award-info":[{"award-number":["W81XWH-16-1-0693"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00581","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T07:12:01Z","timestamp":1744960321000},"page":"e00581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intranasal insulin for improving cognitive function in multiple sclerosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Scott D.","family":"Newsome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Koshorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Pimentel","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimur","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Bayu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo E.","family":"Ravenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ama","family":"Avornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S.","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Romba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Muschelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Mowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurot.2025.e00581_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1355617706060723","article-title":"Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)","volume":"12","author":"Benedict","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.neurot.2025.e00581_bib2","series-title":"Multiple sclerosis: understanding the cognitive challenges","first-page":"17","article-title":"What we know about cognitive changes in multiple sclerosis","author":"DeLuca","year":"2006"},{"key":"10.1016\/j.neurot.2025.e00581_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7224\/1537-2073-6.1.9","article-title":"Cognitive function in patients with multiple sclerosis: impairment and treatment","volume":"1","author":"Rao","year":"2004","journal-title":"IJMSC"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00415-012-6705-1","article-title":"Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study","volume":"260","author":"Ruet","year":"2013","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00581_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/1352458511426735","article-title":"Unemployment in multiple sclerosis: the contribution of personality and disease","volume":"18","author":"Strober","year":"2012","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00581_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/13854046.2010.511272","article-title":"Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline","volume":"24","author":"Morrow","year":"2010","journal-title":"Clin Neuropsychol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.apmr.2009.09.026","article-title":"Examining the relationship between cognition and driving performance in multiple sclerosis","volume":"91","author":"Schultheis","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.neurot.2025.e00581_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PPA.S8230","article-title":"Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence","volume":"4","author":"Patti","year":"2010","journal-title":"Patient Prefer Adherence"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00581_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00581_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00581_bib11","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.0b013e3182918c6f","article-title":"Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study","volume":"80","author":"Amato","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00581_bib12","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","article-title":"Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years","volume":"58","author":"Amato","year":"2001","journal-title":"Arch Neurol"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00581_bib13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1177\/1352458513485981","article-title":"The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study","volume":"19","author":"Lacy","year":"2013","journal-title":"Mult Scler"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00581_bib14","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e318218107a","article-title":"Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis","volume":"76","author":"Krupp","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00581_bib15","article-title":"Aminopyridines for symptomatic treatment in multiple sclerosis","author":"Solari","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00581_bib16","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1212\/WNL.0b013e31826aac60","article-title":"Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial","volume":"79","author":"Lovera","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00581_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/1352458510367662","article-title":"Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial","volume":"16","author":"Lovera","year":"2010","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00581_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00415-009-5074-x","article-title":"The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial","volume":"256","author":"Morrow","year":"2009","journal-title":"J Neurol"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00581_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2015.05.004","article-title":"Cognitive rehabilitation in multiple sclerosis: a systematic review","volume":"354","author":"Mitolo","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurot.2025.e00581_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/384017","article-title":"Insulin in central nervous system: more than just a peripheral hormome","volume":"2012","author":"Duarte","year":"2012","journal-title":"J Aging Res."},{"issue":"12","key":"10.1016\/j.neurot.2025.e00581_bib21","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1074\/jbc.M111.313080","article-title":"Insulin promotes neuronal survival via the alternatively spliced protein kinase C\u03b4II isoform","volume":"287","author":"Apostolatos","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00581_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(92)90313-X","article-title":"Developmental regulation of insulin in the mammalian central nervous system","volume":"582","author":"Schechter","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00581_bib23","series-title":"CNS Regulation of Carbohydrate Metabolism in Advances In Metabolic Disorders","first-page":"304","author":"LeRoith","year":"1983"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00581_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00581_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00581_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.npp.1301193","article-title":"Intranasal insulin improves memory in humans: superiority of insulin aspart","volume":"32","author":"Benedict","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurot.2025.e00581_bib27","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1210\/jc.2007-2606","article-title":"Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin","volume":"93","author":"Benedict","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurot.2025.e00581_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ijo.0803722","article-title":"Obese men respond to cognitive but not to catabolic brain insulin signaling","volume":"32","author":"Hallschmid","year":"2008","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00581_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurot.2025.e00581_bib32","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1210\/jc.2010-0744","article-title":"Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory","volume":"95","author":"Krug","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00581_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JCP.0b013e31820ebd0e","article-title":"No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia","volume":"31","author":"Fan","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00581_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/JCP.0b013e31828701d0","article-title":"No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia","volume":"33","author":"Fan","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neurot.2025.e00581_bib35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bdi.12006","article-title":"A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder","volume":"14","author":"McIntyre","year":"2012","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.neurot.2025.e00581_bib36","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01547169?term=intranasal+insulin+verbal+memory&amp;rank=1. Accessed July 30, 2015."},{"key":"10.1016\/j.neurot.2025.e00581_bib37","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00581867?term=intranasal+insulin+burns&amp;rank=1. Accessed July 30, 2015."},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc13-1672","article-title":"Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes","volume":"37","author":"Novak","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurot.2025.e00581_bib39","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01595646?term=craft+intranasal+insulin&amp;rank=3. Accessed July 30, 2015."},{"key":"10.1016\/j.neurot.2025.e00581_bib40","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01145482?term=intranasal+insulin+haley&amp;rank=1. Accessed July 30, 2015."},{"key":"10.1016\/j.neurot.2025.e00581_bib41","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2025.e00581_bib42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/ene.12463","article-title":"The Symbol Digit Modalities Test as a sentinel test for cognitive impairment","volume":"21","author":"D\u2019hooghe","year":"2014","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00581_bib43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/1352458508090923","article-title":"Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities test and the MS neuropsychological screening questionnaire","volume":"14","author":"Benedict","year":"2008","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00581_bib44","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1177\/1352458511435717","article-title":"Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials","volume":"18","author":"Benedict","year":"2012","journal-title":"Mult Scler"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00581_bib45","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1177\/1352458514533229","article-title":"Characterizing cognitive function during relapse in multiple sclerosis","volume":"20","author":"Benedict","year":"2014","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1076\/clin.16.3.381.13859","article-title":"Minimal neuropsychological assessment of MS patients: a consensus approach","volume":"16","author":"Benedict","year":"2002","journal-title":"Clin Neuropsychol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00581_bib47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458511431076","article-title":"Recommendations for a Brief international cognitive assessment for multiple sclerosis (BICAMS)","volume":"18","author":"Langdon","year":"2012","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00581_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1155\/2012\/105471","article-title":"Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome","volume":"25","author":"Panou","year":"2012","journal-title":"Behav Neurol"},{"key":"10.1016\/j.neurot.2025.e00581_bib49","unstructured":"Benedict R. Brief visuospatial memory test-revised: professional manual. Lutz, FL: Psychological Assessment Resources, Inc."},{"key":"10.1016\/j.neurot.2025.e00581_bib50","series-title":"Contributions to neuropsychological assessment: a clinical manual","author":"Benton","year":"1994"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00581_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13803390600672163","article-title":"Validity of the Wisconsin card sorting and delis-kaplan executive function system (DKEFS) sorting tests in multiple sclerosis","volume":"29","author":"Parmenter","year":"2007","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00581_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1076\/clin.16.3.381.13859","article-title":"Minimal neuropsychological assessment of MS patients: a consensus approach","volume":"16","author":"Benedict","year":"2002","journal-title":"Clin Neuropsychol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00581_bib53","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/1352458509106212","article-title":"Assessing disability progression with the multiple sclerosis functional composite","volume":"15","author":"Rudick","year":"2009","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00581_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/WNL.47.1.129","article-title":"Validation of the functional assessment of multiple sclerosis quality of life instrument","volume":"47","author":"Cella","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00581_bib55","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00581_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103204","article-title":"Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosis","volume":"55","author":"Cederberg","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00581_bib57","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000207301","article-title":"Longitudinal changes in cognitive test scores in patients with relapsing-remitting multiple sclerosis: an analysis of the DECIDE dataset","volume":"101","author":"Castrogiovanni","year":"2023","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00581_bib58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00581_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33657","article-title":"Promising brain biodistribution of insulin via intranasal dry powder for nose-to-brain delivery","volume":"10","author":"Muntu","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00581_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40266-021-00845-7","article-title":"A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild alzheimer's disease","volume":"38","author":"Rosenbloom","year":"2021","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00581_bib61","first-page":"222","article-title":"Safety and efficacy of intranasal insulin in patients with Alzheimer's disease: a systematic review and meta-analysis","volume":"9","author":"AboEl-Azm","year":"2023","journal-title":"J Clin Transl Res"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00581_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae188","article-title":"Effect of intranasal insulin on perioperative cognitive function in older adults: a randomized, placebo-controlled, double-blind clinical trial","volume":"53","author":"Sun","year":"2024","journal-title":"Age Ageing"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00581_bib63","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1007\/s00415-022-11119-6","article-title":"Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial","volume":"269","author":"Novak","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.neurot.2025.e00581_bib64","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:00:25Z","timestamp":1755090025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925000595"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00581","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal insulin for improving cognitive function in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00581"}}